Brian Fredrick Abeysekera

Title: Brian Fredrick Abeysekera: Innovator in Radiopharmaceuticals

Introduction

Brian Fredrick Abeysekera is a notable inventor based in Burnaby, Canada. He has made significant contributions to the field of radiopharmaceuticals, particularly through his innovative processes. His work focuses on enhancing the preparation of radiohalogenated radiopharmaceuticals, which are crucial in medical imaging and treatment.

Latest Patents

Abeysekera holds a patent for a process that involves the preparation of radiopharmaceuticals. This process utilizes electrophilic substitution, specifically halogenodestannylation reactions. The method involves the reaction of an organometallic substituted precursor with a radioactive halogen, such as iodine, astatine, or bromine. This reaction occurs in the presence of a catalytically effective amount of an anion selected from bromide, chloride, and nitrite anion in an acid medium with an oxidizing agent. His innovative approach has led to advancements in the efficiency and effectiveness of radiopharmaceutical production. He has 1 patent to his name.

Career Highlights

Brian Fredrick Abeysekera is currently employed at Guilford Pharmaceuticals, Inc. His role at the company allows him to apply his expertise in radiopharmaceuticals and contribute to the development of new medical technologies. His work is instrumental in advancing the field and improving patient outcomes.

Collaborations

Abeysekera has collaborated with notable colleagues, including Robert Jean Marie Denis Pirotte and David Peter Nowotnik. These collaborations have fostered innovation and have been essential in the development of new methodologies in radiopharmaceuticals.

Conclusion

Brian Fredrick Abeysekera is a distinguished inventor whose work in radiopharmaceuticals has made a significant impact in the medical field. His innovative processes and collaborations continue to drive advancements in this important area of research.